A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-17
DOI
10.1038/s41386-019-0590-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
- (2016) Ragy R. Girgis et al. PSYCHOPHARMACOLOGY
- Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [11C]-(+)-PHNO
- (2015) Ragy R. Girgis et al. SCHIZOPHRENIA RESEARCH
- Parametric Imaging and Test-Retest Variability of 11C-(+)-PHNO Binding to D2/D3 Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner
- (2014) J.-D. Gallezot et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis and in vivo evaluation of [18F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([18F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates
- (2013) Vattoly J. Majo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain
- (2013) J.S. Dileep Kumar et al. BRAIN RESEARCH
- Determination of the In Vivo Selectivity of a New -Opioid Receptor Antagonist PET Tracer 11C-LY2795050 in the Rhesus Monkey
- (2013) S. J. Kim et al. JOURNAL OF NUCLEAR MEDICINE
- Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study
- (2012) S Selvaraj et al. MOLECULAR PSYCHIATRY
- No change in [11C]CUMI-101 binding to 5-HT1A receptors after intravenous citalopram in human
- (2012) Lars H. Pinborg et al. SYNAPSE
- Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: Quantitative analysis, test–retest reproducibility, and vulnerability to endogenous 5-HT tone
- (2011) Peter S. Talbot et al. NEUROIMAGE
- Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO
- (2011) Romina Mizrahi et al. SCHIZOPHRENIA RESEARCH
- Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist
- (2010) Graham Searle et al. BIOLOGICAL PSYCHIATRY
- Imaging Cortical Dopamine D1 Receptors Using [11C]NNC112 and Ketanserin Blockade of the 5-HT2A Receptors
- (2010) Ana M Catafau et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- In Vivo Quantification of Human Serotonin 1A Receptor Using 11C-CUMI-101, an Agonist PET Radiotracer
- (2010) M. S. Milak et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy
- (2010) Andri C. Tziortzi et al. NEUROIMAGE
- In Vivo Binding of Antipsychotics to D3 and D2 Receptors: A PET Study in Baboons with [11C]-(+)-PHNO
- (2010) Ragy R Girgis et al. NEUROPSYCHOPHARMACOLOGY
- The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors
- (2009) Ariel Graff-Guerrero et al. ARCHIVES OF GENERAL PSYCHIATRY
- In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice
- (2009) Eugenii A. Rabiner et al. SYNAPSE
- [C-11]CUMI-101 an agonist 5-HT1A positron emission tomography (PET) tracer in human: Preliminary test–retest data
- (2008) Matthew S. Milak et al. NEUROIMAGE
- Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride
- (2008) Lawrence S Kegeles et al. NEUROPSYCHOPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started